{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:32:47Z","timestamp":1793143967538,"version":"4.5.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"44","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U22A20291"],"award-info":[{"award-number":["U22A20291"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173267"],"award-info":[{"award-number":["82173267"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82500266"],"award-info":[{"award-number":["82500266"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQN26H080002"],"award-info":[{"award-number":["LQN26H080002"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,11,18]]},"DOI":"10.1038\/s41388-026-03992-6","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:36:38Z","timestamp":1790346998000},"page":"4808-4826","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A positive feedback loop between YTHDC1 and EP300 drives multiple myeloma tumorigenesis"],"prefix":"10.1038","volume":"45","author":[{"given":"Yifan","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiqi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwei","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enfan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruyi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyao","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoguang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinna","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunnan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenfeng","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongying","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunting","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlu","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingsong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5636-6704","authenticated-orcid":false,"given":"Pengxu","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6026-3804","authenticated-orcid":false,"given":"Zhen","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"key":"3992_CR1","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/S0140-6736(21)00135-5","volume":"397","author":"N van de Donk","year":"2021","unstructured":"van de Donk N, Pawlyn C, Yong KL. Multiple myeloma. Lancet. 2021;397:410\u201327.","journal-title":"Lancet"},{"key":"3992_CR2","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1056\/NEJMra1011442","volume":"364","author":"A Palumbo","year":"2011","unstructured":"Palumbo A, Anderson K. Multiple myeloma. N Engl J Med. 2011;364:1046\u201360.","journal-title":"N Engl J Med"},{"key":"3992_CR3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.semcancer.2017.09.007","volume":"51","author":"M Alzrigat","year":"2018","unstructured":"Alzrigat M, P\u00e1rraga AA, Jernberg-Wiklund H. Epigenetics in multiple myeloma: from mechanisms to therapy. Semin Cancer Biol. 2018;51:101\u201315.","journal-title":"Semin Cancer Biol"},{"key":"3992_CR4","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.1073\/pnas.71.10.3971","volume":"71","author":"R Desrosiers","year":"1974","unstructured":"Desrosiers R, Friderici K, Rottman F. Identification of methylated nucleosides in messenger RNA from Novikoff hepatoma cells. Proc Natl Acad Sci USA 1974;71:3971\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3992_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0092-8674(74)90153-6","volume":"1","author":"R Perry","year":"1974","unstructured":"Perry R, Kelley D. Existence of methylated messenger RNA in mouse L cells. Cell. 1974;1:37\u201342.","journal-title":"Cell"},{"key":"3992_CR6","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1016\/j.cell.2012.05.003","volume":"149","author":"KD Meyer","year":"2012","unstructured":"Meyer KD, Saletore Y, Zumbo P, Elemento O, Mason CE, Jaffrey SR. Comprehensive analysis of mRNA methylation reveals enrichment in 3\u2019 UTRs and near stop codons. Cell. 2012;149:1635\u201346.","journal-title":"Cell"},{"key":"3992_CR7","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nature11112","volume":"485","author":"D Dominissini","year":"2012","unstructured":"Dominissini D, Moshitch-Moshkovitz S, Schwartz S, Salmon-Divon M, Ungar L, Osenberg S, et al. Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature. 2012;485:201\u20136.","journal-title":"Nature"},{"key":"3992_CR8","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/nmeth.3453","volume":"12","author":"B Linder","year":"2015","unstructured":"Linder B, Grozhik AV, Olarerin-George AO, Meydan C, Mason CE, Jaffrey SR. Single-nucleotide-resolution mapping of m6A and m6Am throughout the transcriptome. Nat Methods. 2015;12:767\u201372.","journal-title":"Nat Methods"},{"key":"3992_CR9","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41580-019-0168-5","volume":"20","author":"S Zaccara","year":"2019","unstructured":"Zaccara S, Ries RJ, Jaffrey SR. Reading, writing and erasing mRNA methylation. Nat Rev Mol Cell Biol. 2019;20:608\u201324.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3992_CR10","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nrg3724","volume":"15","author":"Y Fu","year":"2014","unstructured":"Fu Y, Dominissini D, Rechavi G, He C. Gene expression regulation mediated through reversible m\u2076A RNA methylation. Nat Rev Genet. 2014;15:293\u2013306.","journal-title":"Nat Rev Genet"},{"key":"3992_CR11","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41422-018-0040-8","volume":"28","author":"Y Yang","year":"2018","unstructured":"Yang Y, Hsu PJ, Chen YS, Yang YG. Dynamic transcriptomic m(6)A decoration: writers, erasers, readers and functions in RNA metabolism. Cell Res. 2018;28:616\u201324.","journal-title":"Cell Res"},{"key":"3992_CR12","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41571-023-00774-x","volume":"20","author":"X Deng","year":"2023","unstructured":"Deng X, Qing Y, Horne D, Huang H, Chen J. The roles and implications of RNA m(6)A modification in cancer. Nat Rev Clin Oncol. 2023;20:507\u201326.","journal-title":"Nat Rev Clin Oncol"},{"key":"3992_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06036-z","volume":"14","author":"Y Jia","year":"2023","unstructured":"Jia Y, Yu X, Liu R, Shi L, Jin H, Yang D, et al. PRMT1 methylation of WTAP promotes multiple myeloma tumorigenesis by activating oxidative phosphorylation via m6A modification of NDUFS6. Cell Death Dis. 2023;14:512.","journal-title":"Cell Death Dis"},{"key":"3992_CR14","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s41388-021-02095-8","volume":"41","author":"J Qu","year":"2022","unstructured":"Qu J, Hou Y, Chen Q, Chen J, Li Y, Zhang E, et al. RNA demethylase ALKBH5 promotes tumorigenesis in multiple myeloma via TRAF1-mediated activation of NF-\u03baB and MAPK signaling pathways. Oncogene. 2022;41:400\u201313.","journal-title":"Oncogene"},{"key":"3992_CR15","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1038\/s41388-023-02675-w","volume":"42","author":"R Liu","year":"2023","unstructured":"Liu R, Miao J, Jia Y, Kong G, Hong F, Li F, et al. N6-methyladenosine reader YTHDF2 promotes multiple myeloma cell proliferation through EGR1\/p21(cip1\/waf1)\/CDK2-Cyclin E1 axis-mediated cell cycle transition. Oncogene. 2023;42:1607\u201319.","journal-title":"Oncogene"},{"key":"3992_CR16","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.ymthe.2021.12.012","volume":"30","author":"A Xu","year":"2022","unstructured":"Xu A, Zhang J, Zuo L, Yan H, Chen L, Zhao F, et al. FTO promotes multiple myeloma progression by posttranscriptional activation of HSF1 in an m(6)A-YTHDF2-dependent manner. Mol Ther. 2022;30:1104\u201318.","journal-title":"Mol Ther"},{"key":"3992_CR17","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/s41417-022-00429-6","volume":"30","author":"C Wang","year":"2023","unstructured":"Wang C, Li L, Li M, Wang W, Jiang Z. FTO promotes Bortezomib resistance via m6A-dependent destabilization of SOD2 expression in multiple myeloma. Cancer Gene Ther. 2023;30:622\u20138.","journal-title":"Cancer Gene Ther"},{"key":"3992_CR18","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13045-021-01066-6","volume":"14","author":"F Jiang","year":"2021","unstructured":"Jiang F, Tang X, Tang C, Hua Z, Ke M, Wang C, et al. HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA. J Hematol Oncol. 2021;14:54.","journal-title":"J Hematol Oncol"},{"key":"3992_CR19","doi-asserted-by":"publisher","first-page":"7760","DOI":"10.7150\/thno.76852","volume":"12","author":"R Liu","year":"2022","unstructured":"Liu R, Zhong Y, Chen R, Chu C, Liu G, Zhou Y, et al. m(6)A reader hnRNPA2B1 drives multiple myeloma osteolytic bone disease. Theranostics. 2022;12:7760\u201374.","journal-title":"Theranostics"},{"key":"3992_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12:31\u201346.","journal-title":"Cancer Discov"},{"key":"3992_CR21","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.molcel.2020.06.017","volume":"79","author":"C Zhang","year":"2020","unstructured":"Zhang C, Chen L, Peng D, Jiang A, He Y, Zeng Y, et al. METTL3 and N6-methyladenosine promote homologous recombination-mediated repair of DSBs by modulating DNA-RNA hybrid accumulation. Mol Cell. 2020;79:425\u201342.e427.","journal-title":"Mol Cell"},{"key":"3992_CR22","doi-asserted-by":"publisher","first-page":"3633","DOI":"10.1111\/cas.15503","volume":"113","author":"S Zhang","year":"2022","unstructured":"Zhang S, Xiong Y, Wang W, Zhang E, Gu Y, Liu Y, et al. Identification of the crosstalk among four types of adenosine-related RNA modification in pan-cancer. Cancer Sci. 2022;113:3633\u20136.","journal-title":"Cancer Sci"},{"key":"3992_CR23","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.tig.2021.06.014","volume":"38","author":"RL Kan","year":"2022","unstructured":"Kan RL, Chen J, Sallam T. Crosstalk between epitranscriptomic and epigenetic mechanisms in gene regulation. Trends Genet. 2022;38:182\u201393.","journal-title":"Trends Genet"},{"key":"3992_CR24","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S0076-6879(08)02617-7","volume":"448","author":"CY Chen","year":"2008","unstructured":"Chen CY, Ezzeddine N, Shyu AB. Messenger RNA half-life measurements in mammalian cells. Methods Enzymol. 2008;448:335\u201357.","journal-title":"Methods Enzymol"},{"key":"3992_CR25","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/nmeth.2688","volume":"10","author":"JD Buenrostro","year":"2013","unstructured":"Buenrostro JD, Giresi PG, Zaba LC, Chang HY, Greenleaf WJ. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat Methods. 2013;10:1213\u20138.","journal-title":"Nat Methods"},{"key":"3992_CR26","doi-asserted-by":"publisher","first-page":"W739","DOI":"10.1093\/nar\/gkac382","volume":"50","author":"A Ianevski","year":"2022","unstructured":"Ianevski A, Giri AK, Aittokallio T. SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples. Nucleic Acids Res. 2022;50:W739\u201343.","journal-title":"Nucleic Acids Res"},{"key":"3992_CR27","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/nchembio.1654","volume":"10","author":"C Xu","year":"2014","unstructured":"Xu C, Wang X, Liu K, Roundtree IA, Tempel W, Li Y, et al. Structural basis for selective binding of m6A RNA by the YTHDC1 YTH domain. Nat Chem Biol. 2014;10:927\u20139.","journal-title":"Nat Chem Biol"},{"key":"3992_CR28","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/ajh.27327","volume":"99","author":"MJ Rees","year":"2024","unstructured":"Rees MJ, Kumar S. High-risk multiple myeloma: redefining genetic, clinical, and functional high-risk disease in the era of molecular medicine and immunotherapy. Am J Hematol. 2024;99:1560\u201375.","journal-title":"Am J Hematol"},{"key":"3992_CR29","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1182\/blood.2023020276","volume":"143","author":"N Leblay","year":"2024","unstructured":"Leblay N, Ahn S, Tilmont R, Poorebrahim M, Maity R, Lee H, et al. Integrated epigenetic and transcriptional single-cell analysis of t(11;14) multiple myeloma and its BCL2 dependency. Blood. 2024;143:42\u201356.","journal-title":"Blood"},{"key":"3992_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-022-01314-7","volume":"14","author":"L Zhang","year":"2022","unstructured":"Zhang L, Zhang R, Wang J, Chen Y, Qiao C, Shi Q, et al. Identification of clinical implications and potential prognostic models of chromatin regulator mutations in multiple myeloma. Clin Epigenetics. 2022;14:93.","journal-title":"Clin Epigenetics"},{"key":"3992_CR31","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1158\/2643-3230.BCD-23-0062","volume":"5","author":"SJ Welsh","year":"2024","unstructured":"Welsh SJ, Barwick BG, Meermeier EW, Riggs DL, Shi CX, Zhu YX, et al. Transcriptional heterogeneity overcomes super-enhancer disrupting drug combinations in multiple myeloma. Blood Cancer Discov. 2024;5:34\u201355.","journal-title":"Blood Cancer Discov"},{"key":"3992_CR32","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41420-022-01040-2","volume":"8","author":"H Yan","year":"2022","unstructured":"Yan H, Zhang L, Cui X, Zheng S, Li R. Roles and mechanisms of the m(6)A reader YTHDC1 in biological processes and diseases. Cell Death Discov. 2022;8:237.","journal-title":"Cell Death Discov"},{"key":"3992_CR33","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/emboj.2010.318","volume":"30","author":"Q Jin","year":"2011","unstructured":"Jin Q, Yu LR, Wang L, Zhang Z, Kasper LH, Lee JE, et al. Distinct roles of GCN5\/PCAF-mediated H3K9ac and CBP\/p300-mediated H3K18\/27ac in nuclear receptor transactivation. EMBO J. 2011;30:249\u201362.","journal-title":"EMBO J"},{"key":"3992_CR34","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.chembiol.2010.03.006","volume":"17","author":"EM Bowers","year":"2010","unstructured":"Bowers EM, Yan G, Mukherjee C, Orry A, Wang L, Holbert MA, et al. Virtual ligand screening of the p300\/CBP histone acetyltransferase: identification of a selective small molecule inhibitor. Chem Biol. 2010;17:471\u201382.","journal-title":"Chem Biol"},{"key":"3992_CR35","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jneumeth.2007.04.012","volume":"164","author":"TA Ponzio","year":"2007","unstructured":"Ponzio TA, Yue C, Gainer H. An intron-based real-time PCR method for measuring vasopressin gene transcription. J Neurosci Methods. 2007;164:149\u201354.","journal-title":"J Neurosci Methods"},{"key":"3992_CR36","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1042\/bj3150021","volume":"315","author":"EA Slee","year":"1996","unstructured":"Slee EA, Zhu H, Chow SC, MacFarlane M, Nicholson DW, Cohen GM. Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32. Biochem J. 1996;315:21\u20134.","journal-title":"Biochem J"},{"key":"3992_CR37","doi-asserted-by":"publisher","first-page":"721","DOI":"10.3324\/haematol.2020.274480","volume":"107","author":"K Ponnusamy","year":"2022","unstructured":"Ponnusamy K, Tzioni MM, Begum M, Robinson ME, Caputo VS, Katsarou A, et al. The innate sensor ZBP1-IRF3 axis regulates cell proliferation in multiple myeloma. Haematologica. 2022;107:721\u201332.","journal-title":"Haematologica"},{"key":"3992_CR38","doi-asserted-by":"publisher","first-page":"9516","DOI":"10.1021\/acs.jmedchem.4c00599","volume":"67","author":"F Z\u00e1le\u0161\u00e1k","year":"2024","unstructured":"Z\u00e1le\u0161\u00e1k F, Nai F, Herok M, Bochenkova E, Bedi RK, Li Y, et al. Structure-based design of a potent and selective YTHDC1 ligand. J Med Chem. 2024;67:9516\u201335.","journal-title":"J Med Chem"},{"key":"3992_CR39","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1182\/blood.2021011707","volume":"138","author":"Y Sheng","year":"2021","unstructured":"Sheng Y, Wei J, Yu F, Xu H, Yu C, Wu Q, et al. A critical role of nuclear m6A reader YTHDC1 in leukemogenesis by regulating MCM complex-mediated DNA replication. Blood. 2021;138:2838\u201352.","journal-title":"Blood"},{"key":"3992_CR40","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.ccell.2021.04.017","volume":"39","author":"Y Cheng","year":"2021","unstructured":"Cheng Y, Xie W, Pickering BF, Chu KL, Savino AM, Yang X, et al. N(6)-Methyladenosine on mRNA facilitates a phase-separated nuclear body that suppresses myeloid leukemic differentiation. Cancer Cell. 2021;39:958\u201372.e958.","journal-title":"Cancer Cell"},{"key":"3992_CR41","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/s41375-024-02451-z","volume":"39","author":"X Li","year":"2025","unstructured":"Li X, Zheng M, Ma S, Nie F, Yin Z, Liang Y, et al. YTHDC1 is a therapeutic target for B-cell acute lymphoblastic leukemia by attenuating DNA damage response through the KMT2C-H3K4me1\/me3 epigenetic axis. Leukemia. 2025;39:308\u201322.","journal-title":"Leukemia"},{"key":"3992_CR42","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/s41587-021-00949-w","volume":"39","author":"PN Pratanwanich","year":"2021","unstructured":"Pratanwanich PN, Yao F, Chen Y, Koh CWQ, Wan YK, Hendra C, et al. Identification of differential RNA modifications from nanopore direct RNA sequencing with xPore. Nat Biotechnol. 2021;39:1394\u2013402.","journal-title":"Nat Biotechnol"},{"key":"3992_CR43","doi-asserted-by":"crossref","unstructured":"Zhu Y, Wang Z, Li Y, Peng H, Liu J, Zhang J, et al. The role of CREBBP\/EP300 and its therapeutic implications in hematological malignancies. Cancers. 2023;15:1219.","DOI":"10.3390\/cancers15041219"},{"key":"3992_CR44","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1158\/0008-5472.CAN-25-3440","volume":"86","author":"WF Lenoir","year":"2026","unstructured":"Lenoir WF, McKeown MR, Giorgetti G, Kobylarz MJ, Hopkins TD, Glore WL, et al. Catalytic inhibition of p300 preferentially targets IRF4 oncogenic activity and tumor growth in multiple myeloma. Cancer Res. 2026;86:1010\u201334.","journal-title":"Cancer Res"},{"key":"3992_CR45","doi-asserted-by":"publisher","first-page":"4935","DOI":"10.7150\/thno.73223","volume":"12","author":"Q Chen","year":"2022","unstructured":"Chen Q, Yang B, Liu X, Zhang XD, Zhang L, Liu T. Histone acetyltransferases CBP\/p300 in tumorigenesis and CBP\/p300 inhibitors as promising novel anticancer agents. Theranostics. 2022;12:4935\u201348.","journal-title":"Theranostics"},{"key":"3992_CR46","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1016\/j.ccell.2023.11.001","volume":"41","author":"L Nicosia","year":"2023","unstructured":"Nicosia L, Spencer GJ, Brooks N, Amaral FMR, Basma NJ, Chadwick JA, et al. Therapeutic targeting of EP300\/CBP by bromodomain inhibition in hematologic malignancies. Cancer Cell. 2023;41:2136\u201353.e2113.","journal-title":"Cancer Cell"},{"key":"3992_CR47","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41392-024-01980-4","volume":"9","author":"L Wang","year":"2024","unstructured":"Wang L, Zhu Y, Zhang N, Xian Y, Tang Y, Ye J, et al. The multiple roles of interferon regulatory factor family in health and disease. Signal Transduct Target Ther. 2024;9:282.","journal-title":"Signal Transduct Target Ther"},{"key":"3992_CR48","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nature07064","volume":"454","author":"AL Shaffer","year":"2008","unstructured":"Shaffer AL, Emre NC, Lamy L, Ngo VN, Wright G, Xiao W, et al. IRF4 addiction in multiple myeloma. Nature. 2008;454:226\u201331.","journal-title":"Nature"},{"key":"3992_CR49","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.tig.2022.10.004","volume":"39","author":"I Orsolic","year":"2023","unstructured":"Orsolic I, Carrier A, Esteller M. Genetic and epigenetic defects of the RNA modification machinery in cancer. Trends Genet. 2023;39:74\u201388.","journal-title":"Trends Genet"},{"key":"3992_CR50","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/s41556-023-01213-w","volume":"25","author":"X Dou","year":"2023","unstructured":"Dou X, Xiao Y, Shen C, Wang K, Wu T, Liu C, et al. RBFOX2 recognizes N(6)-methyladenosine to suppress transcription and block myeloid leukaemia differentiation. Nat Cell Biol. 2023;25:1359\u201368.","journal-title":"Nat Cell Biol"},{"key":"3992_CR51","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1038\/s41588-023-01568-8","volume":"55","author":"R Li","year":"2023","unstructured":"Li R, Zhao H, Huang X, Zhang J, Bai R, Zhuang L, et al. Super-enhancer RNA m(6)A promotes local chromatin accessibility and oncogene transcription in pancreatic ductal adenocarcinoma. Nat Genet. 2023;55:2224\u201334.","journal-title":"Nat Genet"},{"key":"3992_CR52","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.stem.2020.04.001","volume":"27","author":"J Wang","year":"2020","unstructured":"Wang J, Li Y, Wang P, Han G, Zhang T, Chang J, et al. Leukemogenic chromatin alterations promote AML leukemia stem cells via a KDM4C-ALKBH5-AXL signaling axis. Cell Stem Cell. 2020;27:81\u201397.e88.","journal-title":"Cell Stem Cell"},{"key":"3992_CR53","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1136\/gutjnl-2019-319639","volume":"69","author":"Q Wang","year":"2020","unstructured":"Wang Q, Chen C, Ding Q, Zhao Y, Wang Z, Chen J, et al. METTL3-mediated m(6)A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance. Gut. 2020;69:1193\u2013205.","journal-title":"Gut"},{"key":"3992_CR54","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41593-017-0057-1","volume":"21","author":"Y Wang","year":"2018","unstructured":"Wang Y, Li Y, Yue M, Wang J, Kumar S, Wechsler-Reya RJ, et al. N(6)-methyladenosine RNA modification regulates embryonic neural stem cell self-renewal through histone modifications. Nat Neurosci. 2018;21:195\u2013206.","journal-title":"Nat Neurosci"},{"key":"3992_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.xgen.2024.100605","volume":"4","author":"C Li","year":"2024","unstructured":"Li C, Chen K, Fang Q, Shi S, Nan J, He J, et al. Crosstalk between epitranscriptomic and epigenomic modifications and its implication in human diseases. Cell Genom. 2024;4:100605.","journal-title":"Cell Genom"},{"key":"3992_CR56","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1182\/blood-2006-07-037077","volume":"109","author":"F Zhan","year":"2007","unstructured":"Zhan F, Barlogie B, Arzoumanian V, Huang Y, Williams DR, Hollmig K, et al. Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis. Blood. 2007;109:1692\u2013700.","journal-title":"Blood"},{"key":"3992_CR57","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.1158\/1078-0432.CCR-12-3461","volume":"19","author":"K Todoerti","year":"2013","unstructured":"Todoerti K, Agnelli L, Fabris S, Lionetti M, Tuana G, Mosca L, et al. Transcriptional characterization of a prospective series of primary plasma cell leukemia revealed signatures associated with tumor progression and poorer outcome. Clin Cancer Res. 2013;19:3247\u201358.","journal-title":"Clin Cancer Res"},{"key":"3992_CR58","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/sj.leu.2404520","volume":"21","author":"NC Guti\u00e9rrez","year":"2007","unstructured":"Guti\u00e9rrez NC, Ocio EM, de Las Rivas J, Maiso P, Delgado M, Fermi\u00f1\u00e1n E, et al. Gene expression profiling of B lymphocytes and plasma cells from Waldenstr\u00f6m\u2019s macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals. Leukemia. 2007;21:541\u20139.","journal-title":"Leukemia"},{"key":"3992_CR59","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1158\/1078-0432.CCR-09-2831","volume":"16","author":"NJ Dickens","year":"2010","unstructured":"Dickens NJ, Walker BA, Leone PE, Johnson DC, Brito JL, Zeisig A, et al. Homozygous deletion mapping in myeloma samples identifies genes and an expression signature relevant to pathogenesis and outcome. Clin Cancer Res. 2010;16:1856\u201364.","journal-title":"Clin Cancer Res"},{"key":"3992_CR60","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/sj.leu.2404253","volume":"20","author":"I Hanamura","year":"2006","unstructured":"Hanamura I, Huang Y, Zhan F, Barlogie B, Shaughnessy J. Prognostic value of cyclin D2 mRNA expression in newly diagnosed multiple myeloma treated with high-dose chemotherapy and tandem autologous stem cell transplantations. Leukemia. 2006;20:1288\u201390.","journal-title":"Leukemia"},{"key":"3992_CR61","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1182\/blood-2017-09-808063","volume":"131","author":"Y Jin","year":"2018","unstructured":"Jin Y, Chen K, De Paepe A, Hellqvist E, Krstic AD, Metang L, et al. Active enhancer and chromatin accessibility landscapes chart the regulatory network of primary multiple myeloma. Blood. 2018;131:2138\u201350.","journal-title":"Blood"},{"key":"3992_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0736-8","volume":"16","author":"EM Pugacheva","year":"2015","unstructured":"Pugacheva EM, Rivero-Hinojosa S, Espinoza CA, M\u00e9ndez-Catal\u00e1 CF, Kang S, Suzuki T, et al. Comparative analyses of CTCF and BORIS occupancies uncover two distinct classes of CTCF binding genomic regions. Genome Biol. 2015;16:161.","journal-title":"Genome Biol"},{"key":"3992_CR63","doi-asserted-by":"crossref","unstructured":"Cocco M, Care MA, Saadi A, Al-Maskari M, Doody G, Tooze R. A dichotomy of gene regulatory associations during the activated B-cell to plasmablast transition. Life Sci Alliance. 2020;3:e202000654.","DOI":"10.26508\/lsa.202000654"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03992-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03992-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03992-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:02:28Z","timestamp":1793142148000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03992-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":63,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2026,11,18]]}},"alternative-id":["3992"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03992-6","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"assertion":[{"value":"27 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This study was approved by the Ethics Committee of the First Affiliated Hospital, Zhejiang University School of Medicine. All procedures involving human samples were conducted in accordance with the principles of the Declaration of Helsinki. Written informed consent was obtained from all participants prior to sample collection. Participant confidentiality and anonymity were strictly protected throughout the study.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}